IVE vs XBI
iShares S&P 500 Value ETF vs SPDR S&P Biotech ETF
IVE$223.58
iShares S&P 500 Value ETF
S&P 500 value subset.
Expense: 0.18%Yield: 1.54%
XBI$133.66
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.34%
Quick take
- • IVE has the lower expense ratio at 0.18% vs 0.35% for XBI.
- • IVE pays a higher dividend yield (1.54%).
Side-by-side metrics
| Metric | IVE | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.18% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.54% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $49.37B | $8.30B |
YTD return | 6.38% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.83 | 1.09 |
P/E ratio | 23.37 | — |
Last price | $223.58 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
IVE top holdings
Top holdings · IVE
| AAPL | Apple Inc | 6.98% |
| AMZN | Amazon.com Inc | 4.26% |
| XOM | Exxon Mobil Corp | 2.26% |
| WMT | Walmart Inc | 2.03% |
| COST | Costco Wholesale Corp | 1.58% |
| INTC | Intel Corp | 1.55% |
| TSLA | Tesla Inc | 1.43% |
| CVX | Chevron Corp | 1.27% |
| BAC | Bank of America Corp | 1.24% |
| PG | Procter & Gamble Co | 1.20% |
Sector breakdown · IVE
Real Estate3.5%
Consumer Cyclical11.0%
Basic Materials3.4%
Consumer Defensive9.5%
Technology19.6%
Communication Services3.3%
Financial Services15.2%
Utilities4.6%
Industrials10.7%
Energy7.6%
Healthcare11.6%
XBI top holdings
Top holdings · XBI
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
Sector breakdown · XBI
Financial Services0.2%
Healthcare99.8%
About IVE
IVE (iShares S&P 500 Value ETF) is S&P 500 value subset. Managed by iShares, the fund carries $49.4B in assets under management, an expense ratio of 0.18%, a dividend yield of 1.54%. Its largest holding is Apple Inc (AAPL), which represents 7.0% of the portfolio. Real Estate is the fund's largest sector exposure at 3.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.